Show results for
Refine by
Brain Lesion Equipment & Supplies
6 equipment items found
Manufactured by:inomed Medizintechnik GmbH based inEmmendingen, GERMANY
The LG2-sEEG Lesion Generator is one of the new devices in the inomed RF Lesion Generator series. In combination with the sEEG-Box, it is possible to perform RF treatments via sEEG electrodes. sEEG (stereoelectroencephalography) is an invasive, diagnostic procedure for patients with drug-resistant ...
Manufactured by:Fiagon AG Medical Technologies based inHennigsdorf (Berlin), GERMANY
A procedure to remove a sample of abnormal tissue is called a brain biopsy and allows a neurosurgeon the diagnosis of a brain lesion. After the decision for this procedure, the BiopsyPointer is guided by the CUBE4D in the preoperative CT or MRI scan and enables a direct and constant guidance for the surgeon. ...
Manufactured by:ABCDx based inGeneva, SWITZERLAND
With a drop of blood from a finger prick at the point of care, TBICheck™ allows to rapidly discharge patients with a suspected brain ...
Manufactured by:Precirix based inBrussels, BELGIUM
Our lead product candidate, CAM-H2, consists of an HER2-targeting single-domain antibody linked to iodine-131. This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such as breast and gastric adenocarcinoma. In addition to the company’s lead program, two product candidates for undisclosed oncology targets are ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Phenothiazine is an antibiotic which has insecticidal, fungicidal, antibacterial and anthelmintic activities. Phenothiazine also can be used for the research of neurological ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of β-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sjögren’s syndrome and type I diabetes ...